Get the Stockscreener App
1.56
5.20%
0.08
Ocugen Inc stock is traded at $1.56, with a volume of 1.03M.
It is up +5.20% in the last 24 hours and down -4.48% over the past month.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
See More
Previous Close:
$1.48
Open:
$1.5
24h Volume:
1.03M
Relative Volume:
0.24
Market Cap:
$456.00M
Revenue:
-
Net Income/Loss:
$-63.08M
P/E Ratio:
-5.7778
EPS:
-0.27
Net Cash Flow:
$-72.53M
1W Performance:
-3.30%
1M Performance:
-4.48%
6M Performance:
+108.36%
1Y Performance:
+70.90%
1-Day Range:
$1.49
$1.58
1-Week Range:
$1.47
$1.65
52-Week Range:
$0.515
$1.90
Ocugen Inc Stock (OCGN) Company Profile
Name
Ocugen Inc
Sector
Industry
Phone
484-328-4701
Address
11 GREAT VALLEY PARKWAY, MALVERN, PA
Compare OCGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.56 | 462.21M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.72 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
658.35 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.96 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
815.60 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.41 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-24 | Initiated | Maxim Group | Buy |
| Mar-01-23 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Aug-23-22 | Initiated | Mizuho | Buy |
| Jun-15-22 | Resumed | ROTH Capital | Buy |
| Jun-02-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-26-21 | Initiated | Noble Capital Markets | Outperform |
| Jun-11-21 | Downgrade | ROTH Capital | Buy → Neutral |
| May-07-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Feb-09-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Feb-04-21 | Upgrade | H.C. Wainwright | Neutral → Buy |
View All
Ocugen Inc Stock (OCGN) Latest News
How high can Ocugen Inc. stock goJuly 2025 Selloffs & Technical Confirmation Trade Alerts - newser.com
Is Ocugen Inc. stock ready for breakoutJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Will Ocugen Inc. stock outperform tech sector in 2025Portfolio Value Summary & Low Risk Entry Point Tips - newser.com
Is Ocugen Inc. still worth holding after the dipJuly 2025 EndofMonth & Accurate Entry and Exit Point Alerts - newser.com
Will Ocugen Inc. stock see insider buyingDividend Hike & High Accuracy Investment Signals - newser.com
Is it time to cut losses on Ocugen Inc.Market Movement Recap & Free Technical Pattern Based Buy Signals - newser.com
Is Ocugen Inc. (2H51) stock resilient in recession scenariosM&A Rumor & AI Forecasted Stock Moves - newser.com
Analyzing net buyer seller activity in Ocugen Inc.Quarterly Earnings Report & Free Fast Entry Momentum Trade Alerts - newser.com
Is Ocugen Inc. stock attractive for growth ETFs2025 Key Highlights & Low Risk Investment Opportunities - newser.com
Price momentum metrics for Ocugen Inc. explained2025 Technical Overview & Smart Investment Allocation Tips - newser.com
Combining price and volume data for Ocugen Inc.July 2025 Highlights & Expert Approved Momentum Ideas - newser.com
Using economic indicators to assess Ocugen Inc. potentialEarnings Risk Report & Risk Controlled Swing Trade Alerts - newser.com
Ocugen (OCGN) to Release Quarterly Earnings on Wednesday - MarketBeat
How Ocugen Inc. stock reacts to job market dataJuly 2025 Retail & Safe Capital Preservation Plans - newser.com
How Ocugen Inc. (2H51) stock trades pre earnings2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Identifying reversal signals in Ocugen Inc.2025 Institutional Moves & Weekly Breakout Watchlists - newser.com
Best data tools to analyze Ocugen Inc. stockQuarterly Profit Summary & Verified Entry Point Signals - newser.com
Ocugen (OCGN) Price Target Increased by 26.15% to 8.36 - Nasdaq
Will Ocugen Inc. stock maintain dividend yieldEarnings Recap Summary & Daily Profit Maximizing Trade Tips - newser.com
Will Ocugen Inc. (2H51) stock maintain strong growthJuly 2025 Final Week & AI Powered Buy and Sell Recommendations - Fundação Cultural do Pará
Why Ocugen Inc. (2H51) stock is favored by hedge fundsMarket Sentiment Summary & AI Forecast for Swing Trade Picks - newser.com
Why millennials buy Ocugen Inc. (2H51) stockJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
Ocugen Inc Stock (OCGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.54%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):